Over the 90-day window ending January 09, 2026, Nuvectis Pharma's three dominant insider ownership positions are held by TenPercentOwner Marlio Charles Mosseri (5.75Mn shares), Chairman & Ceo Ron Bentsur (3.53Mn shares), Chief Science & Business Off Enrique Poradosu (1.66Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Marlio Charles Mosseri | 5,748,576 | 16 Dec, 2024 | |
| Ron Bentsur | Chairman & Ceo | 3,525,924 | 06 Nov, 2025 |
| Enrique Poradosu | Chief Science & Business Off | 1,656,319 | 03 Jan, 2025 |
| Shay Shemesh | Chief Dev. & Ops. Officer | 1,643,068 | 03 Jan, 2025 |
| Michael J. Carson | Vice President And Finance | 138,918 | 03 Jan, 2025 |
| Kenneth Hoberman | 133,140 | 12 Jun, 2025 | |
| Matthew L. Kaplan | 124,760 | 06 Nov, 2025 | |
| James F Iii Oliviero | 87,828 | 12 Jun, 2025 | |
| Juan Sanchez | 78,150 | 06 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Nov, 2025 | Ron Bentsur | Common Stock | A | 5,000 | $5.72 | 3,525,924 | D | P |
| 05 Nov, 2025 | Matthew L. Kaplan | Common Stock | A | 11,000 | $5.84 | 124,760 | D | P |
| 05 Nov, 2025 | Juan Sanchez | Common Stock | A | 13,000 | $5.79 | 78,150 | D | P |
| 27 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 72,836 | $6.28 | 3,136,576 | I | P |
| 24 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 35,034 | $6.15 | 3,063,740 | I | P |
| 23 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 46,900 | $6.06 | 3,028,706 | I | P |
| 22 Sep, 2025 | Juan Sanchez | Common Stock | A | 30,000 | $0.00 | 65,150 | D | A |
| 20 Jun, 2025 | Marlio Charles Mosseri | - | - | 2,981,806 | I | |||
| 20 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 5,603 | $7.99 | 2,981,806 | I | P |
| 18 Jun, 2025 | Marlio Charles Mosseri | - | - | 2,976,203 | I | |||
| 18 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 28,043 | $8.05 | 2,976,203 | I | P |
| 17 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 5,399 | $8.11 | 2,948,160 | I | P |
| 12 Jun, 2025 | James F Iii Oliviero | Common Stock | A | 30,000 | $0.00 | 87,828 | D | A |
| 12 Jun, 2025 | Kenneth Hoberman | Common Stock | A | 30,000 | $0.00 | 133,140 | D | A |
| 12 Jun, 2025 | Matthew L. Kaplan | Common Stock | A | 30,000 | $0.00 | 113,760 | D | A |
| 12 Jun, 2025 | Matthew L. Kaplan | - | - | 113,760 | D | |||
| 12 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 21,167 | $8.11 | 2,942,761 | I | P |
| 09 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 9,850 | $8.95 | 2,921,382 | I | P |
| 09 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 9,817 | $8.90 | 2,931,199 | I | P |
| 09 May, 2025 | Marlio Charles Mosseri | - | - | 2,936,594 | I |